--- title: CROs offering Preclinical In Vivo Studies with Biologics (Other) path: /explore/preclinical-in-vivo/biologics-other companies_count: 29 --- # CROs offering Preclinical In Vivo Studies with Biologics (Other) 29 published CROs match Preclinical In Vivo Studies and Biologics (Other). Locations in this set include United States, China, India, Netherlands, United Kingdom, and Canada. Capabilities that show up most often in this set: Preclinical In Vitro Studies, In Vivo PK / PD Studies, Translational Research, In Vivo Efficacy Models, and GLP Toxicology. ## Matching companies - [Accelera Srl](/companies/accelera) - Europe-based preclinical CRO specializing in GLP-compliant toxicology, safety assessment, and efficacy testing for small molecules and biologics, with AAALAC accreditation and integrated translational research capabilities. - [Allucent](/companies/allucent) - Allucent is a full-service CRO specializing in clinical development solutions for small and mid-sized biotech companies. - [Altasciences](/companies/altasciences) - Mid-size early phase CRO/CDMO in Canada and the U.S. offering preclinical safety testing, clinical pharmacology (Phase I–II), bioanalysis, research services, and manufacturing with integrated capabilities. - [Aragen Life Sciences](/companies/aragen) - Global CRDMO partner offering integrated discovery-to-commercialization services across small molecules and biologics, with 4000+ scientists and R&D/manufacturing campuses in Asia, North America, and Europe. - [BioDuro-Sundia](/companies/bioduro-sundia) - BioDuro-Sundia is a contract research, development, and manufacturing organization (CRDMO) with 30 years of expertise providing integrated drug discovery, development, and manufacturing services from target identification through IND submission. - [Certara](/companies/certara) - Certara transforms drug development with proprietary biosimulation software, predictive modeling, and AI-driven services spanning discovery through commercialization. Serving 2,400+ biopharmaceutical companies and regulatory agencies across 70 countries, Certara's model-informed drug development (MIDD) platform accelerates clinical and regulatory decision-making. - [Champions Oncology](/companies/championsoncology) - Leading oncology CRO specializing in preclinical and clinical specialty testing, with over 1,400 patient-derived xenograft models, comprehensive multi-omic datasets, and proprietary platforms including flow cytometry, NGS, proteomics, and histopathology services. - [ChemPartner](/companies/chempartner) - Global preclinical CRO with 20+ years of experience supporting drug discovery through IND submission across small molecules and biologics, with 2,000+ scientists and facilities worldwide. - [Creative Bioarray](/companies/creative-bioarray) - Creative Bioarray provides preclinical research solutions including drug screening, ADME-PK, toxicity studies, and cell-based services across oncology, neurology, cardiovascular, and metabolic therapeutic areas. - [Crown Bioscience](/companies/crownbio) - Preclinical oncology CRO offering 2,500+ PDX models, organoid and cell line databases, and translational platforms with biomarker discovery and AI-driven systems biology for drug development. - [Esco Aster](/companies/escoaster) - Esco Aster is a vertically integrated CDMO and CRO delivering end-to-end contract solutions from process development and GMP manufacturing through clinical research, with specialized capabilities in vaccine production, cell therapy, plasmid DNA, extracellular vesicles, and GLP toxicology. - [Evotec](/companies/evotec) - Evotec is a life science company pioneering drug discovery and preclinical development. The organization leverages cutting-edge technology, disruptive science, and extensive disease knowledge to accelerate the journey from concept to cure. - [ITR Laboratories](/companies/itrlab) - GLP-compliant nonclinical CRO specializing in safety and toxicology testing across in silico, in vitro, and in vivo modalities, with 35+ years of experience and nearly 6,000 completed studies. - [InnoSer Laboratories](/companies/innoserlaboratories) - Preclinical CRO offering GLP and non-GLP toxicology, custom genetically modified mouse models, and disease models across oncology, neurology, immunology, metabolic, and cardiovascular research. Supports programs from target discovery through IND-enabling studies. - [JOINN Biomere](/companies/biomere) - Boston-area preclinical CRO specializing in non-GLP PK/PD and early toxicology studies in rodent and large animal models, including primates. AAALAC accredited with extensive vivarium capacity and multidisciplinary scientific support. - [Labcorp](/companies/labcorp) - Labcorp is a global life sciences and healthcare company providing diagnostic testing, drug development, nonclinical research, central laboratory services, and real-world data solutions to healthcare providers, health systems, and biopharma companies. - [Medpace](/companies/medpace) - Full-service CRO with 30+ years of organic growth, offering integrated clinical development services across all phases with wholly-owned central labs, bioanalytical lab, imaging core lab, and Phase I unit. - [Noble Life Sciences](/companies/noblelifesci) - Advanced preclinical CRO providing comprehensive drug and device development services including bioanalysis, GLP toxicology, pharmacodynamic modeling, and specialized testing for oncology, infectious disease, gene therapy, and synthetic biology programs. - [NorthEast BioLab](/companies/nebiolab) - Bioanalytical CRO providing PK/PD, immunogenicity (ADA/nAb), cytokine, and biomarker assays across LC-MS, Meso Scale Discovery, ELISA, and ddPCR platforms. Operates GLP/GCLP-compliant facilities and reports DEA and CT approval for Schedule I–IV bioanalysis. - [Oncodesign Services](/companies/oncodesign-services) - Contract research organization specializing in drug discovery and preclinical services for oncology, inflammation, and infectious diseases since 1995.